Curvebeam Ai Ltd. · ASX:CVB
Curvebeam Ai — Shareholder Meeting (November 2025)
10 slides from Curvebeam Ai's shareholder meeting presentation, Nov 27, 2025
Slide 1: CurveBeamAI AGM Presentation
For personal use only CURVEBEAMAI AGM PRESENTATION 27 November 2025
Slide 2: Disclaimer
DISCLAIMER Introduction Forward looking statements THIS PRESENTATION IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, The information given in this presentation is given for illustrative purposes only and should not be relied upon as For personal use only DIRECTLY OR INDIRECTLY,
Slide 3: CVB AGM - FY25 Key Highlights
CVB AGM - FY25 KEY HIGHLIGHTS • CurveBeam AI • FY2024 Revenue was ~$6.5m AUD For personal use only Share Price Performance • FY 2025 Revenue was ~$12.1m AUD • Revenue growth of around ~ 86% increase in sales YoY • FY24 loss from ordinary activities ~ $23m AUD • FY25 Loss from ordinary activities ~ $
Slide 4: China Strategy: Targeted Strategic Benefits
CHINA STRATEGY TA R G E T E D S T R AT E G I C B E N E F I T S For personal use only ü Capital Injection with Reduced Dilution - A$10m at 40.5 cents – milestone based ü A new path to target material sales/profit – linked with Wego surgical Robot using WBCT ü China will be initially supplied US HiRis
Slide 5: China Agreements Key Terms
China Agreements Key terms Share Subscription Agreement • Equity Investment - The Partner will make an equity investment of up to A$10 million in CVB as & Voluntary Escrow Deed follows: For personal use only • Execution of license agreements A$4 million milestone payment. • HiRiseTM sold generating
Slide 6: FY24 to FY25 Cumulative Purchase Orders Analysis
FY24 TO FY25 CUMMULATIVE PURCHASE ORDERS ANALYSIS For personal use only TM Discontinued ® 6 AGM PRESENTATION
Slide 7: Enhanced HiRise Validation in Knee/Hip
E N H A N C E D H I R I S E ™ VA L I D AT I O N I N K N E E / H I P What is a robotic cut guide For personal use only Validation ongoing with multiple suppliers of knee products • CVB is currently working to validate HiRise™ for multiple knee suppliers for non-robotic surgery – 1) Restor3d/Conformis
Slide 8: Robotic Market Dynamics – Drives Dependence
ROBOTIC MARKET DYNAMICS – DRIVES DEPENDENCE 1. Robotic system adoption for orthopedics continues at a steady pace with ~ 25% of US operating rooms having access to a robot - Source Global Data 2023 2. Stryker MAKO, J&J VELYS, Zimmer ROSA and S&N CORI – held 85% of the market - Source Global Data 202
Slide 9: BMD SaaS MDCT Module Update
BMD SAAS MDCT MODULE UPDATE For personal use only Multidetector CT (MDCT) • As presented in the quarterly activity report for Q1 FY 25, the Company’s revised BMD regulatory strategy is to clear the first BMD module on multidetector CT (MDCT) scanners, the primary technology used today. • This strate
Slide 10: WBCT Competitors – Update
W B C T C O M P E T I T O R S – U P D AT E For personal use only PlanMed XFI – WBCT – in development/future competition PlanMed Verity • US FDA clearance announced • Available today – FDA, CE, TGA • Space & height limits access in group surgeon settings • Partial foot, Ankle, knee • No automated mul